On-track for trem-cel and VCAR33ALLO clinical updates in the second half of 2024Trem-cel trial expanded to include patients with myelodysplastic syndromes (MDS); Mylotargâ„¢ dosing has advanced to ...
What are those strange white cones in fields and what do they have to do with aviation? Although they’ve been around since the 1930s and widely in use since the 1970s, VOR (pronounced “VEE OH ...
**Wer ist in deiner Familie?**Who’s in your family? Hier ist meine Familie. Here’s my family. Let’s start with my mother, meine Mutter, and my father, mein Vater. Or meine Schwester, my ...
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
Vor Bio's Trem-cel Shows Early Encouraging Data In Leukemia Patients Vor Biopharma Inc (NASDAQ: VOR) presented updated data from patients treated in the VBP101 Phase 1/2a study of trem-cel ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to ...